Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration recently approved two new treatments to reduce the severity of nasolabial folds or "laugh lines" in adults.
Biopharmaceutical company JHL Biotech and Sanofi entered into a strategic alliance granting Sanofi exclusive rights to manufacture and market its own proposed biosimilar of JHL Biotech's drug Rituximab in China. Under the contract, JHL Biotech would be entitled to up…
The rising price of the opioid-antidote drug naloxone may hinder national efforts to reduce opioid-related deaths, according to a new report published in The New England Journal of Medicine.
When President-elect Donald Trump steps enters the White House Jan. 20, one of the first business tax breaks he makes will likely revolve around the medical device industry, reports Reuters.
The first generic version of Roche's best-selling flu medication Tamiflu entered the U.S. market Monday, reports Reuters.
Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that the London-based drugmaker improperly marketed and promoted its anti-psychotic drug Abilify, reports Reuters.
The Chinese government's National Development and Reform Commission fined Medtronic 118.5 million yuan ($17 million) for allegedly setting a minimum price on its medical devices and barring dealers and distributors from discounting them to patients, reports The Wall Street Journal.
About 157,000 American workers quit their manufacturing jobs in October, representing the largest rate in more than eight years, according to a new survey from the U.S. Department of Labor.
Citron Research's tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company's stock to fall as much as 9 percent Thursday, reports Investor's Business Daily.
Supply chain professionals have an ethical responsibility to initiate more sustainable practices within the industry, according to Kevin O'Marah, chief content officer of SCM World, a global community of supply chain professionals.